Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure
Horng H. Chen, John C. Burnett(Mayo Clinic in Arizona), Lynda J. Nordstrom(Mayo Clinic), Margaret M. Redfield(Mayo Clinic in Arizona), Darlene P. Horton(Scion)
Cited by 65
Related Papers
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
|American Heart Journal|2005|2.1k
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
|Circulation Heart Failure|2010|1.1k
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
|Circulation|2015|848
Endothelin in human congestive heart failure.
|Circulation|1994|588